As oncology care becomes increasingly complex, traditional attribution models used in value-based care programs may no longer fully reflect how patients are treated in the real world. In this BioPharma Boardroom interview, Jill Hellmann, MSN, RN, Tra... Read more
As oncology care becomes increasingly personalized and technology-enabled, digital tools are playing a growing role in improving patient outcomes beyond the clinic walls. In this exclusive BioPharma Boardroom interview, Dr. Debra Patt, MD, PhD, MBA, ... Read more
As oncology practices face increasing patient demand and looming workforce shortages, advanced practice providers (APPs) are becoming an essential part of delivering timely, high-quality cancer care. In this BioPharma Boardroom interview, Eileen Vell... Read more
As biotech companies navigate increasingly complex pathways from scientific discovery to commercial success, the importance of location, expertise, and ecosystem has never been greater. In this exclusive conversation with BioPharma BoardRoom, Kirsten... Read more
Q1 2026 Group performance Comparable order intake growth 6% Group sales of EUR 3.9 billion, reflecting 4% increase in comparable sales Income from operations increased to EUR 241 million Adjusted EBITA margin increased 40 basis points t... Read more
Financial performance Q1 2026 reported sales increased by 32% at CER, positively impacted by a provision reversal related to the 340B Drug Pricing Program in the US. Q1 2026 adjusted sales, excluding the 340B provision reversal, decreased... Read more
AGC Biologics, your friendly CDMO expert, was selected by Teikoku Seiyaku Co., Ltd., a leader in transdermal drug delivery, to provide microbial contract development and manufacturing services for KTP-001, a recombinant human matrix metalloproteina... Read more
LOTTE Biologics (Co-CEOs James Park and Yooyeol Shin) announce an expansion of its collaboration with Ottimo Pharma, an innovative biotech company developing one-of-a-kind PD-1/VEGFR2 dual-paratopic antibodies, reinforcing a growing strategic ... Read more
© 2026 Biopharma Boardroom. All Rights Reserved.
